GL1X · GenesisL1 explorer

Ligand · DO2

DO2 · 5,5-dihydroxy-6-oxo-L-norleucine

DO2, 5,5-dihydroxy-6-oxo-L-norleucine (C6 H11 N O5, 177.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found…

Component
DO2
Formula
C6 H11 N O5
Class
ligand
Structures
2
PDB entries
1

Binding sites

DO2 in 2 structures; the first of them:

  • 1DJP · Crystal structure of pseudomonas 7A glutaminase-asparaginase with the inhibitor don… · DO2 A4000 · binds GLY1019, THR1020, TYR1034, ALA1036, ALA1066, SER1067, GLU1068, GLY1099 and 7 more
  • 1DJP · Crystal structure of pseudomonas 7A glutaminase-asparaginase with the inhibitor don… · DO2 A4000 · binds GLY1019, THR1020, TYR1034, ALA1036, ALA1066, SER1067, GLU1068, GLY1099 and 7 more

Residues it binds most

SER 4, ALA 4, GLU 4, GLY 4, THR 4, ASP 4, MET 4, TYR 4, LYS 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.